Journal Article Summary
The article investigates the effectiveness of montelukast, a leukotriene receptor antagonist, as an additional treatment for chronic idiopathic urticaria (CIU), a skin condition characterized by recurrent hives and swelling without a known cause. This topic is significant because CIU can severely impact a person's quality of life, and conventional treatments, primarily antihistamines, do not work for everyone. The study aims to explore whether adding montelukast can help patients who do not achieve adequate symptom relief with antihistamines alone.
In this observational study, researchers analyzed data from nine patients at a dermatology clinic who were treated with montelukast alongside antihistamines. The patients, mostly middle-aged women, had been suffering from CIU for two to ten years. Results showed that four patients experienced a good response to montelukast, with three achieving complete control of their symptoms within weeks of starting the medication. The study measured the effectiveness using the urticaria activity score (UAS), indicating that montelukast may significantly improve symptoms for some patients resistant to antihistamines.
However, the study has limitations, including a small sample size, which means more research is needed to confirm these findings. Patients should be aware that while montelukast appears to be a safe option with minimal side effects, it may not work for everyone. It is essential for individuals with CIU to discuss their treatment options with a healthcare professional, especially if they are not finding relief with current therapies, to ensure they receive personalized care that addresses their specific needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Alkeraye Salim, AlRuhaimi Danah K. The Addition of Montelukast for the Treatment of Chronic Idiopathic Urticaria. Cureus 2021. DOI: 10.7759/cureus.16137. PMID: 34354881. PMCID: PMC8327886.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
